← Back to Search

Behavioral Intervention

iHERO Resource Group for Type 1 Diabetes

N/A

Waitlist Available

Led By Julia Blanchette, PhD

Research Sponsored by Julia Blanchette

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 1 month, 6 months, 12 months

Awards & highlights

Study Summary

This trial aims to test a toolkit called iHERO designed for young adults with type 1 diabetes to help them manage their diabetes, financial stress, and health insurance literacy. The study will involve participants

Who is the study for?

The iHERO study is for young adults with type 1 diabetes, particularly those using Medicaid and from diverse racial or ethnic backgrounds. Participants will engage in the study at four different times over a year, filling out surveys and completing an A1c test via Zoom.Check my eligibility

What is being tested?

This trial tests the iHERO Toolkit Resource designed to help manage financial stress and improve health insurance literacy among young adults with type 1 diabetes. The impact on self-management of diabetes will be measured through surveys and A1c levels.See study design

What are the potential side effects?

Since this trial involves educational resources rather than medical treatments, there are no direct physical side effects expected from participating in the iHERO Toolkit intervention.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 1 month, 6 months, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 1 month, 6 months, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in HbA1c levels as measured by self-collect capillary HbA1c

Change in diabetes-specific quality of life as measured by The Type 1 Diabetes and Life Young Adult (T1DAL- Young Adult) for ages 18-25 or The Type 1 Diabetes and Life (T1DAL- Adult) for Ages 26-30.

Change in financial stress as measured by the Personal Financial Well-Being Scale© (PFW) Scale (PFW)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: iHERO Resource GroupExperimental Treatment1 Intervention

Toolkit consisting of micro-videos and supplemental online resources.

Group II: ControlActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Julia BlanchetteLead Sponsor

The Leona M. and Harry B. Helmsley Charitable TrustOTHER

57 Previous Clinical Trials

93,701 Total Patients Enrolled

Julia Blanchette, PhDPrincipal InvestigatorUniversity Hospitals

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

At how many different sites is this study currently being conducted?

"The ongoing clinical trial is underway at four different sites, including Gainesville, Cleveland, and Philadelphia among others. Opting for a site nearest to you can reduce the burden of travel during your participation in the study."

Answered by AI

Are there still available openings for new participants in this research study?

"As per the data on clinicaltrials.gov, this particular study is currently not open for patient recruitment. Although it was initially posted on May 1st, 2024 and last updated on March 29th, 2024. Nevertheless, amidst 1276 ongoing trials actively seeking participants at present."

Answered by AI

Am I eligible to be a participant in this clinical trial?

"Eligible participants must have a diagnosis of type 1 diabetes and fall between the ages of 18 and 30 to qualify for enrollment in this research. The study aims to recruit a total of 192 individuals."

Answered by AI

Is this medical research open to individuals who have reached adulthood, typically considered as 18 years of age or older?

"Applicants aged between 18 and 30 years are eligible for this clinical investigation. Notably, there exist a notable number of studies catering to individuals under 18 as well as those over 65 years old."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes

Julia Blanchette 2024. "iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06348160.